Will Nations Share Their COVID-19 Vaccines?
This story is a part of Science Friday’s coverage on the novel coronavirus, the agent of the disease COVID-19. Listen to experts discuss the spread, outbreak response, and treatment.
As American pharmaceutical company Moderna’s COVID-19 vaccine candidate entered Phase 3 of human clinical trials this week—an important step in what is still an early phase of its development—Russia claims a vaccine of its own will be approved for use as soon as mid-August, prompting safety concerns. But questions about vaccines extend far beyond who is first. What happens next for the people around the world waiting for protection from the pandemic? As Science Magazine reports, rich nations have placed hundreds of millions of advance orders for successful vaccines, while poorer countries worry that there will be little left for everyone else.
Maggie Koerth, senior science reporter for FiveThirtyEight, discusses this story and more news from the week, including the discovery of 100-million-year-old microbes living beneath the ocean floor.
Invest in quality science journalism by making a donation to Science Friday.
Maggie Koerth is a senior science reporter with FiveThirtyEight.com. She’s based in Minneapolis, Minnesota.
John Dankosky works with the radio team to create our weekly show, and is helping to build our State of Science Reporting Network. He’s also been a long-time guest host on Science Friday. He and his wife have four cats, thousands of bees, and a yoga studio in the sleepy Northwest hills of Connecticut.